Quest Diagnostics has introduced a new blood test aimed at assisting physicians in confirming amyloid brain pathology related ...

For years, researchers primarily focused their attention on another protein, beta-amyloid, as the cause of Alzheimer's. While ...

There's still so much we don't know about Alzheimer's disease, but the link between poor sleep and worsening disease is one ...

There's new research linking senolytics to helping slow down Alzheimer's progression. Here's how and what experts have to say ...

Delve into how the biotech industry is pivoting from the amyloid hypothesis to find new Alzheimer's disease treatments.

Experimental drug NU-9 - a small molecule compound approved by the U.S. Food and Drug Administration (FDA) for clinical trials for the treatment of amyotrophic lateral sclerosis (ALS) - improves ...

Alzheimer’s disease is notorious for robbing individuals of memory and cognitive function. Researchers have struggled for ...

According to the authors, the research opens up new possibilities for developing the next generation of ChE inhibitors that ...

Researchers from National Taiwan University and collaborators have developed a novel way to observe and monitor carbon ...

Knight says that the method of transmission that Collinge identified is “extremely unusual,” and there’s no evidence that ...

Research shows diabetes medications may cut Alzheimer's risk by up to 43% in patients with type 2 diabetes, offering ...

Researchers used data from more than 92,000 people with type 2 diabetes. They found that two medications significantly ...